Invention Application
- Patent Title: AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER
-
Application No.: US17628382Application Date: 2020-07-17
-
Publication No.: US20220273809A1Publication Date: 2022-09-01
- Inventor: Maarten JANMAAT , Nora PENCHEVA , Esther Cornelia Wilhelmina BREIJ , Julia BOSHUIZEN , Daniel Simon PEEPER , Ulf FORSSMANN , Tahamtan AHMADI , Patricia Garrido CASTRO
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- International Application: PCT/EP2020/070348 WO 20200717
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61P35/00 ; A61K47/02
Abstract:
The present invention relates to conjugates of antibodies and cytotoxic agents for use in treatment of cancer in combination with an inhibitor of PD-1 or PD-L1. The antibodies are directed against Axl.
Information query
IPC分类:
